Flow Cytometric Analysis of CD133- and EpCAM-Positive Cells in the Peripheral Blood of Patients with Lung Cancer
暂无分享,去创建一个
[1] J. Thomson,et al. Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.
[2] M Vasei,et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers , 2006, British Journal of Cancer.
[3] M. Biffoni,et al. Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.
[4] Youngwook Kim,et al. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung. , 2009, Anticancer research.
[5] O. Gires,et al. EpCAM (CD326) finding its role in cancer , 2007, British Journal of Cancer.
[6] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[7] A. Stenzl,et al. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry : a valuable tool for diagnosis and prognosis evaluation , 2013 .
[8] E. Raso,et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. , 2006, Cancer research.
[9] Hans Clevers,et al. The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.
[10] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[12] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[13] G. Tsavellas,et al. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells , 2004, Clinical & Experimental Metastasis.
[14] M. Krzakowski. [Recommendations on systemic treatment of non-small cell lung cancer and maligant pleural mesothelioma]. , 2010, Pneumonologia i alergologia polska.
[15] Liquid Biopsies. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[16] M. Rots,et al. EpCAM in carcinogenesis: the good, the bad or the ugly. , 2010, Carcinogenesis.
[17] Yuh-Lih Chang,et al. Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells , 2008, PloS one.
[18] R. Elashoff,et al. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer , 2009, BMC Cancer.
[19] G. Viglietto,et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[21] M C Miller,et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] R. Czajka,et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood – preliminary report , 2007, Leukemia.
[23] E. Smit,et al. CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients , 2009, British Journal of Cancer.
[24] Caroline Dive,et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] E. Bettelli,et al. Arch.Immunol.Ther.Exp. , 2000 .
[26] P. Dalerba,et al. Identification of pancreatic cancer stem cells. , 2006, Cancer research.
[27] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[28] G. Kallergi,et al. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. , 2010, Cancer letters.
[29] Wei Liu,et al. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry , 2012, Tumor Biology.
[30] Cai-yun Zhou,et al. Stage-Specific Embryonic Antigen 4 Expression in Epithelial Ovarian Carcinoma , 2010, International Journal of Gynecologic Cancer.
[31] Anthony J Alberg,et al. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[32] J. Schellens,et al. Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. , 2012, Lung cancer.
[33] M. Ratajczak,et al. Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis , 2005, Stem cells.